FR2794369B1 - Traitement de la maladie de peyronie - Google Patents

Traitement de la maladie de peyronie

Info

Publication number
FR2794369B1
FR2794369B1 FR0006863A FR0006863A FR2794369B1 FR 2794369 B1 FR2794369 B1 FR 2794369B1 FR 0006863 A FR0006863 A FR 0006863A FR 0006863 A FR0006863 A FR 0006863A FR 2794369 B1 FR2794369 B1 FR 2794369B1
Authority
FR
France
Prior art keywords
peyronia
disease
treatment
peyronia disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
FR0006863A
Other languages
English (en)
Other versions
FR2794369A1 (fr
Inventor
Thomas L Wegman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADVANDE BIOFACTURES OF CURACAO
Original Assignee
ADVANDE BIOFACTURES OF CURACAO
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADVANDE BIOFACTURES OF CURACAO filed Critical ADVANDE BIOFACTURES OF CURACAO
Publication of FR2794369A1 publication Critical patent/FR2794369A1/fr
Application granted granted Critical
Publication of FR2794369B1 publication Critical patent/FR2794369B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4886—Metalloendopeptidases (3.4.24), e.g. collagenase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
FR0006863A 1999-06-03 2000-05-29 Traitement de la maladie de peyronie Expired - Lifetime FR2794369B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/325,224 US6022539A (en) 1999-06-03 1999-06-03 Amelioration of peyronie's disease

Publications (2)

Publication Number Publication Date
FR2794369A1 FR2794369A1 (fr) 2000-12-08
FR2794369B1 true FR2794369B1 (fr) 2003-11-21

Family

ID=23266961

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0006863A Expired - Lifetime FR2794369B1 (fr) 1999-06-03 2000-05-29 Traitement de la maladie de peyronie

Country Status (9)

Country Link
US (1) US6022539A (fr)
AU (1) AU3532900A (fr)
CA (1) CA2308842C (fr)
DE (1) DE10027521A1 (fr)
DK (1) DK177177B1 (fr)
FR (1) FR2794369B1 (fr)
GB (1) GB2352173B (fr)
NO (1) NO333945B1 (fr)
SE (1) SE0001914L (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2197018B1 (es) * 2002-06-06 2005-10-01 Especialidades Farmaceuticas Centrum Sa Nuevo uso terapeutico de los extractos de polypodium.
MX2007008764A (es) * 2005-01-21 2007-10-19 Advance Biofactures Corp Metodos para tratar capsulitis adhesiva.
US20070224184A1 (en) * 2006-02-22 2007-09-27 The Research Foundation Of The State University Of New York Method for treating cellulite
US7811560B2 (en) 2006-01-30 2010-10-12 Auxilium Us Holdings, Llc Compositions and methods for treating collagen-mediated diseases
US8323642B2 (en) * 2006-12-13 2012-12-04 Depuy Mitek, Inc. Tissue fusion method using collagenase for repair of soft tissue
US20080233614A1 (en) * 2007-02-13 2008-09-25 Cranenburgh Rocky M Production of recombinant collagenases colg and colh in escherichia coli
US10071143B1 (en) 2007-05-03 2018-09-11 The Research Foundation For The State University Of New York Methods for non-surgical treatment of carpal tunnel syndrome
US20100159564A1 (en) * 2007-11-30 2010-06-24 Dwulet Francis E Protease resistant recombinant bacterial collagenases
TWI395593B (zh) 2008-03-06 2013-05-11 Halozyme Inc 可活化的基質降解酵素之活體內暫時性控制
US20100061972A1 (en) * 2008-08-19 2010-03-11 Auxilium US Holdings,LLC Method of Treating Peyronie's Disease
US20110229451A2 (en) * 2009-03-06 2011-09-22 Halozyme, Inc. Temperature sensitive mutants of matrix metalloproteases and uses thereof
US8465413B2 (en) 2010-11-25 2013-06-18 Coloplast A/S Method of treating Peyronie's disease
US9180172B2 (en) 2010-12-15 2015-11-10 Ams Research Corporation Treatment of Peyronies disease
US10119131B2 (en) 2011-03-16 2018-11-06 Biospecifics Technologies Corp. Compositions and methods for producing clostridial collagenases
ES2690568T3 (es) 2011-07-20 2018-11-21 Mediwound, Ltd. Extracto proteolítico de bromelaína para el tratamiento de trastornos del tejido conectivo
ES2968836T3 (es) 2012-01-12 2024-05-14 Endo Global Ventures Enzima del clostridium histolyticum
US20180028575A1 (en) 2012-01-30 2018-02-01 Michael Zahalsky Methods and compositions for treatment of penile defects
WO2013116327A1 (fr) * 2012-01-30 2013-08-08 Zahalsky Michael P Procédés et compositions pour le traitement de défauts péniens
US20150196625A9 (en) 2013-01-07 2015-07-16 Rudolph D. Paladini Metal Sensitive Mutants of Matrix Metalloproteases and uses thereof
US9744138B2 (en) 2013-03-15 2017-08-29 Biospecifics Technologies Corp. Treatment method and product for uterine fibroids using purified collagenase
CN103751102A (zh) 2014-01-15 2014-04-30 上海交通大学 一种胶原酶温敏水凝胶及其制备方法和应用
IL301796A (en) 2017-03-01 2023-05-01 Endo Ventures Ltd A method for evaluating and treating cellulite
WO2018183582A2 (fr) * 2017-03-28 2018-10-04 Endo Ventures Limited Procédé de production de collagénase amélioré
EP4045078A1 (fr) 2019-10-15 2022-08-24 The Johns Hopkins University Traitement de fibromes utérins à l'aide de collagénase purifiée

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338300A (en) * 1981-02-05 1982-07-06 The Regents Of The University Of California Use of purified clostridial collangenase in the treatment of Peyronie's disease
AU5045690A (en) * 1989-01-27 1990-08-24 Immunolytics, Inc. Composition and method for treating benign prostatic hypertrophy
US6086872A (en) * 1997-03-27 2000-07-11 Advance Biofactures Of Curacao, Nv Amelioration of dupuytren's disease

Also Published As

Publication number Publication date
DK177177B1 (da) 2012-04-30
IE20000402A1 (en) 2001-01-10
CA2308842A1 (fr) 2000-12-03
FR2794369A1 (fr) 2000-12-08
NO333945B1 (no) 2013-10-28
AU3532900A (en) 2000-12-07
NO20002686L (no) 2000-12-04
SE0001914L (sv) 2000-12-04
GB2352173A (en) 2001-01-24
GB2352173B (en) 2004-11-10
SE0001914D0 (sv) 2000-05-23
CA2308842C (fr) 2013-02-12
US6022539A (en) 2000-02-08
DE10027521A1 (de) 2000-12-07
NO20002686D0 (no) 2000-05-25
DK200000792A (da) 2000-12-04
GB0011969D0 (en) 2000-07-05

Similar Documents

Publication Publication Date Title
FR2794369B1 (fr) Traitement de la maladie de peyronie
CY2018020I1 (el) Θεραπεια της νοσου ρομρε
PT1299729E (pt) Diagnostico precoce de doencas conformacionais
FIU20060389U0 (fi) Luusairauksien hoito
BR9600969A (pt) Método de tratamento de doença inflamatória cardíaca
NO20022974D0 (no) Anvendelse av biologisk aktive vitamin D-forbindelser for forhindring og behandling av inflammatorisk tarmsykdom
MA25413A1 (fr) Fabrication de micromousse therapeutique.
EP1165109A4 (fr) Traitement de maladie auto-immune
CH1143977H1 (fr) 2-Oxy-benzoxazine-4-ones destinees au traitement de l'obesite
NO20042208L (no) Vaginalt administrerte anti-dysrytmiske midler for behandling av bekkensmerter
ID27576A (id) Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
IL147946A0 (en) Treatment of inflammatory or malignant disease using dnazymes
DE60122601D1 (de) Behandlung von entzündlichen Darmerkrankungen
MA25852A1 (fr) Methode pour le traitement de l'inflammation.
AR026062A1 (es) Tratamiento de desordenes oculares
NO20012612L (no) Isonipecotamider for behandlingen av integrin-formidlede sykdommer
ITMI20011820A0 (it) Trattamento di ustioni
NO20030762L (no) Forbedret spesifisitet i behandling av sykdommer
NO20014476D0 (no) Behandling av hiatial hernia
UA25749A (uk) Спосіб хірургічhого лікуваhhя виразкової хвороби шлуhка
FR2797055B1 (fr) Procede de criblage de molecules destinees au traitement de la maladie de huntington
EP1221951A4 (fr) Traitement d'une maladie pancreatique
UA25492A (uk) Спосіб лікуваhhя хвороби гіршпруhга
SE9800359D0 (sv) Pharmaceutical preparation and method for treatment, prevention and diagnosis of gastrooesophageal reflux disease
NO20014092L (no) Behandling av infertilitet

Legal Events

Date Code Title Description
TP Transmission of property
PLFP Fee payment

Year of fee payment: 16

PLFP Fee payment

Year of fee payment: 17

PLFP Fee payment

Year of fee payment: 18

PLFP Fee payment

Year of fee payment: 19

PLFP Fee payment

Year of fee payment: 20